Investors
Specialized pharmaceutical company for creating market value through experience and innovation
Presentations
Poster presentation at SITC 2023 (TU2218)
Poster presentation of TU2218, an oral immune-oncology therapy targeting TGF-beta and VEGF, at the Society for Immunotherapy of Cancer Annual Meeting (SITC) 2023
